Related Experiment Video
Updated: Aug 10, 2026

Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
Importance of laboratory parameters in the evaluation of Crohn's disease activity
Insights
A new laboratory index for Crohn's disease (CD) activity, the LCDAI, complements the clinical CDAI. It detects inflammation not evident clinically, especially in patients in remission, improving CD monitoring.
Area of Science:
- Gastroenterology
- Clinical Chemistry
- Immunology
Background:
- Crohn's disease (CD) management relies on assessing disease activity.
- Existing clinical indices like the Crohn's Disease Activity Index (CDAI) may not capture all inflammatory activity.
Purpose of the Study:
- To develop and validate a laboratory-based index for Crohn's disease activity (LCDAI).
- To assess the relationship between the LCDAI and the conventional CDAI.
- To identify subclinical inflammation in CD patients.
Main Methods:
- 131 examinations from 63 CD patients were analyzed.
- 10 laboratory investigations were performed at each visit.
- A laboratory index (LCDAI) was developed using multiple regression analysis based on expert evaluation of lab results.
- Correlation between LCDAI and CDAI was assessed.
Main Results:
- C-reactive protein, ESR, and WBC count were key components of the LCDAI.
- LCDAI correlated with CDAI in moderate to severe disease.
- LCDAI indicated subclinical inflammation in 55% of patients in clinical remission.
Conclusions:
- The LCDAI effectively reflects inflammatory activity in Crohn's disease.
- Supplementing the clinical CDAI with the LCDAI provides a more comprehensive assessment of disease activity.
- The LCDAI is valuable for detecting subclinical inflammation in CD patients.
Abstract:
Some laboratory investigations are abnormal during the course of Crohn's disease (CD). We investigated the trend of some of these laboratory tests in a group of patients with CD to study the relationships between an activity index made up of such laboratory parameters only (LCDAI) and the usual Crohn's disease activity index (CDAI). One hundred thirty-one examinations of 63 patients were evaluated. At each investigation, besides calculation of the CDAI, 10 laboratory investigations were carried out. Three gastroenterologists independently gave an overall evaluation of the laboratory activity for each of the 131 examinations on the basis of the results of the blood tests alone. The sum of the evaluations was used as an independent variable on which a laboratory index was developed by multiple regression analysis. C reactive protein, red cell sedimentation rate, acid alpha 1-glycoprotein, alpha 1-antitrypsin, and white blood cells had an important share in the development of this laboratory index. The evaluation of the relationships existing between LCDAI and CDAI showed that in patients with moderate to severe clinical disease activity, LCDAI was constantly altered. The same happened in 55% of cases in clinical remission, which suggests an inflammatory activity that is not clinically evident. These results point to the advisability of supplementing a predominantly clinical index, such as CDAI, with a laboratory index such as LCDAI in the evaluation of CD.
More Related Videos
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Serum Laboratory Studies, Stool Test, Breath Test
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease IV: Clinical Manifestations

